Publications by authors named "Sherry De Xuan Du"
Article Synopsis
- This study investigates whether the timing of surgery after neoadjuvant chemotherapy affects disease-free and overall survival in breast cancer patients, as the optimal time frame has often been set between four to eight weeks.
- A total of 259 patients were analyzed, categorized into three groups based on the timing of their surgery: within 28 days, 29-56 days, and after 57 days.
- The results indicate that the timing of surgery did not significantly impact disease-free survival or overall survival, suggesting that more flexibility in scheduling surgeries may be feasible without affecting patient outcomes.
Oncologists have traditionally administered the maximum tolerated doses of drugs in chemotherapy. However, these toxicity-guided doses may lead to suboptimal efficacy. CURATE.
View Article and Find Full Text PDF